183 related articles for article (PubMed ID: 33201407)
1. High expression of NEK2 promotes gastric cancer progression via activating AKT signaling.
Wan H; Xu L; Zhang H; Wu F; Zeng W; Li T
J Physiol Biochem; 2021 Feb; 77(1):25-34. PubMed ID: 33201407
[TBL] [Abstract][Full Text] [Related]
2. NIMA related kinase 2 promotes gastric cancer cell proliferation
Fan WD; Chen T; Liu PJ
World J Gastroenterol; 2019 Jun; 25(23):2898-2910. PubMed ID: 31249448
[TBL] [Abstract][Full Text] [Related]
3. NEK2 promotes the progression of liver cancer by resisting the cellular senescence.
Lei Q; Xia J; Feng X; Guo J; Li G; Zhou W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):153-164. PubMed ID: 35545405
[TBL] [Abstract][Full Text] [Related]
4. Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation.
Wen S; Liu Y; Yang M; Yang K; Huang J; Feng D
Oncol Rep; 2016 Oct; 36(4):2193-9. PubMed ID: 27509921
[TBL] [Abstract][Full Text] [Related]
5. NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase.
Gu Z; Xia J; Xu H; Frech I; Tricot G; Zhan F
J Hematol Oncol; 2017 Jan; 10(1):17. PubMed ID: 28086949
[TBL] [Abstract][Full Text] [Related]
6. High expression of NEK2 promotes lung cancer progression and drug resistance and is regulated by mutant EGFR.
Chen C; Peng S; Li P; Ma L; Gan X
Mol Cell Biochem; 2020 Dec; 475(1-2):15-25. PubMed ID: 32761510
[TBL] [Abstract][Full Text] [Related]
7. Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
Wu SM; Lin SL; Lee KY; Chuang HC; Feng PH; Cheng WL; Liao CJ; Chi HC; Lin YH; Tsai CY; Chen WJ; Yeh CT; Lin KH
Int J Cancer; 2017 Apr; 140(7):1581-1596. PubMed ID: 27925179
[TBL] [Abstract][Full Text] [Related]
8. Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT signaling pathway.
Sun L; Lu T; Tian K; Zhou D; Yuan J; Wang X; Zhu Z; Wan D; Yao Y; Zhu X; He S
Eur J Pharmacol; 2019 Feb; 845():8-15. PubMed ID: 30582908
[TBL] [Abstract][Full Text] [Related]
9. Targeting NEK2 as a promising therapeutic approach for cancer treatment.
Fang Y; Zhang X
Cell Cycle; 2016; 15(7):895-907. PubMed ID: 27019372
[TBL] [Abstract][Full Text] [Related]
10. CircRNA circPDSS1 promotes the gastric cancer progression by sponging miR-186-5p and modulating NEK2.
Ouyang Y; Li Y; Huang Y; Li X; Zhu Y; Long Y; Wang Y; Guo X; Gong K
J Cell Physiol; 2019 Jul; 234(7):10458-10469. PubMed ID: 30417526
[TBL] [Abstract][Full Text] [Related]
11. CGK062, a small chemical molecule, inhibits cancer upregulated gene 2‑induced oncogenesis through NEK2 and β‑catenin.
Kaowinn S; Oh S; Moon J; Yoo AY; Kang HY; Lee MR; Kim JE; Hwang DY; Youn SE; Koh SS; Chung YH
Int J Oncol; 2019 Apr; 54(4):1295-1305. PubMed ID: 30968157
[TBL] [Abstract][Full Text] [Related]
12. ATP5B promotes the metastasis and growth of gastric cancer by activating the FAK/AKT/MMP2 pathway.
Wang X; Chang X; He C; Fan Z; Yu Z; Yu B; Wu X; Hou J; Li J; Su L; Liu B; Zhu Z
FASEB J; 2021 Apr; 35(4):e20649. PubMed ID: 33715234
[TBL] [Abstract][Full Text] [Related]
13. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
[TBL] [Abstract][Full Text] [Related]
14. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
Chen Y; Wu N; Liu L; Dong H; Liu X
J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
[TBL] [Abstract][Full Text] [Related]
15. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.
Lu H; Yao B; Wen X; Jia B
BMC Cancer; 2019 Sep; 19(1):918. PubMed ID: 31519156
[TBL] [Abstract][Full Text] [Related]
16. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
[TBL] [Abstract][Full Text] [Related]
17. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
[TBL] [Abstract][Full Text] [Related]
18. [Recombinant methioninase regulates PI3K/Akt/Glut-1 pathway and inhibits aerobic glycolysis to promote apoptosis of gastric cancer cells].
Zhou L; Li S; Liu L; Zhou Q; Yuan Y; Xin L
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):27-33. PubMed ID: 32376548
[TBL] [Abstract][Full Text] [Related]
19. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
[TBL] [Abstract][Full Text] [Related]
20. NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition.
Zhang Y; Wang W; Wang Y; Huang X; Zhang Z; Chen B; Xie W; Li S; Shen S; Peng B
Oncol Rep; 2018 Mar; 39(3):1023-1033. PubMed ID: 29399700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
